CIBC Private Wealth Group’s Catalyst Pharmaceutical CPRX Stock Holding History

CIBC Private Wealth Group’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$95.5K	Sell	4,091 -1,437	-26%	-$32K	﹤0.01%	1534
2025 Q3	$109K	Buy	5,528 +1,331	+32%	+$27.4K	﹤0.01%	1453
2025 Q2	$91.1K	Sell	4,197 -7	-0.2%	-$165	﹤0.01%	1429
2025 Q1	$90K	Buy	4,204 +202	+5%	+$4.55K	﹤0.01%	1404
2024 Q4	$91.2K	Hold	4,002	–	–	﹤0.01%	1455
2024 Q3	$79.6K	Hold	4,002	–	–	﹤0.01%	1590
2024 Q2	$61.8K	Hold	4,002	–	–	﹤0.01%	1585
2024 Q1	$63K	Buy	+4,002	New	+$60.3K	﹤0.01%	1574
2023 Q1	–	Sell	-50,810	Closed	-$945	–	895
2022 Q4	$945	Buy	+50,810	New	+$782K	﹤0.01%	772

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CIBC Private Wealth Group's CPRX Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Catalyst Pharmaceutical (CPRX) stake by 26% in Q4 2025, selling an estimated $32K and leaving 4,091 shares worth $95.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

CIBC Private Wealth Group first reported a position in CPRX in Q4 2022 and has held it in 9 quarters since. The position peaked at $109K in Q3 2025. 373 funds tracked by Wall St. Rank hold CPRX as of Q4 2025.

CIBC Private Wealth Group held 4,091 shares of Catalyst Pharmaceutical worth $95.5K as of Q4 2025.
CIBC Private Wealth Group sold 1,437 Catalyst Pharmaceutical shares in Q4 2025, an estimated $32K.
Catalyst Pharmaceutical made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1534 holding.
CIBC Private Wealth Group first reported a position in Catalyst Pharmaceutical in Q4 2022 and has held it in 9 quarters since.
CIBC Private Wealth Group's Catalyst Pharmaceutical position peaked at $109K in Q3 2025.
373 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.